Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children

NCT04501718 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Medulloblastoma

Interventions

DRUG: Apatinib Combined With Temozolomide and Etoposide Capsules

Sponsor

Beijing Sanbo Brain Hospital